Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
As we tuck into eggnog and festive cheer, it’s worth taking a pause to look at what might lie ahead for fintech in 2025, especially in the IPO market. After years of turbulence, fintech ...
One exciting thing about the IPO, if it takes place, is that we'd inevitably gain a lot more transparency about the world's largest hotel wholesaler, Hotelbeds. HBX Group, formerly Hotelbeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback